Pain crisis in children with sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how children with sickle cell disease experience pain crises (severe pain episodes that often require hospital care). Researchers want to understand what happens during these crises, which might help improve care and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 18 years old.
- Your child must have a confirmed diagnosis of sickle cell anemia (verified by a blood test).
- Your child must have had at least one hospital visit or admission for a pain crisis (vaso-occlusive crisis).
- Your child must not have other blood disorders like thalassemia.
- Your child must not have other chronic diseases that could affect pain crises.
- Medical records must be complete for the hospital visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether numbing a specific area (regional anesthesia) can reduce inflammation and pain during a sickle cell pain crisis. It may offer a new way to manage severe pain without strong medications.
This study looks at what causes pain in people with sickle cell disease. They hope to learn more about pain patterns to better help patients manage it.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.